TIDES Asia 2026 Archives - Page 2 of 2

24-26 February, 2026
Grand Nikko Tokyo Daiba, Tokyo

TIDES Asia 2026: Bridging Research to Reality

Asia’s Premier Forum Accelerating Therapeutic Breakthroughs from Discovery to Market. The exclusive Asia-Pacific gathering where leaders in oligonucleotide, peptide, mRNA, and genome editing converge to share cutting-edge strategies across discovery, development, and CMC – advancing next-generation therapeutics through collaborative innovation.

Visit their booths, explore their tech, and book meetings to connect with the leaders shaping what’s next.

Connect with the Top Companies Leading The Way in Oligonucleotide & Peptide Therapeutics

Start Connecting

Plan Your Event

Pre-Conference Sessions

Morning Sessions – February 24, 2026 (9:00 AM – 12:30 PM)

Pre-Conference Workshop #1

Regulatory and Practical CMC Considerations Around Novel RNA Chemistries

Why Attend: Essential foundation for understanding manufacturing and regulatory challenges of next-generation oligonucleotide therapeutics.

Value Add: Comprehensive coverage of manufacturing upscale challenges, process-related impurities, and phase-appropriate CMC considerations for novel.

Target Audience: CMC professionals, regulatory affairs specialists, and scientists working with oligonucleotide therapeutics.

Workshop Moderator:

Thomas Rupp
Managing Director, Axolabs Berlin GmbH, Germany

Pre-Conference Workshop #2

Manufacturing and Characterization of Long and/or Complex Peptides

Why Attend: Specialized training on technical considerations and case studies for complex peptide manufacturing.

Value Add: Deep-dive into analytical journey, preparative purification innovations, and synthesis solutions for complex cyclic peptides.

Target Audience: Peptide scientists, process development professionals, and analytical development specialists.

Workshop Moderator:

Bruce Morimoto
Ph.D., Independent Consultant and TIDES Advisor, USA

Networking Opportunities Not to Miss

February 25, 5:15-6:15 PM

Networking Cocktail Reception with Poster and Exhibit Viewing

Why Essential: Prime networking time with beverages, appetizers, and poster viewing in the exhibit hall.

Strategic Value: End-of-day relaxed atmosphere perfect for meaningful conversations with industry peers.

Attendee Mix: Full conference attendance including 50+ visionary speakers, exhibitors, and 300+ delegates from Asia, Europe, and North America.

February 25-26, 10:15-10:55 AM & 3:15-3:45 PM

Daily Networking Refreshment Breaks with Poster and Exhibit Viewing

Why Essential: Fresh energy, coffee, and exhibit hall access when attendees are most engaged.

Strategic Value: Perfect timing between sessions to discuss presentations and connect with 30+ global technology leaders.

Attendee Mix: Active conference participants ready to engage and collaborate on oligonucleotide, peptide, mRNA, and genome editing innovations.

Daily

Networking Luncheons

Why Essential: Extended networking opportunities over meals with poster and exhibit viewing.

Strategic Value: Dedicated time to foster meaningful professional connections and discuss cutting-edge research.

Attendee Mix: Scientists, executives, and technology leaders from leading companies including Eli Lilly, Novo Nordisk, Takeda, Genentech, and more.

Featured throughout February 25-26

TIDES Talks in the Exhibit Hall

Why Essential: Unique 15-minute format combining learning with networking during exhibit hall visits.

Strategic Value: Direct access to technology leaders and innovation showcases in an intimate setting.

Attendee Mix: Technology-focused professionals and potential collaborators seeking real-world solutions.

Not-to-Miss Sessions

Development of New Molecular Technologies for siRNA Therapeutics

Why Critical: Keynote presentation on breakthrough siRNA therapeutic technologies from leading Japanese researcher.

Impact: Insights into next-generation molecular approaches for RNA therapeutics.

Speaker:

Takeshi Wada, Ph.D.
Professor of Organic Chemistry,
Tokyo University of Science, Japan

The Science Behind the GLP-1 Medicines: A Historic View and Future Outlook

Why Critical: Comprehensive overview from the pioneer behind GLP-1 medicine development.

Impact: Historical perspective and future directions for one of the most successful peptide therapeutic classes.

Speaker:

Lotte Bjerre Knudsen, Ph.D.
Chief Scientific Advisor & Head of GLP-1 CoE
Novo Nordisk A/S, Denmark

Clinical Development of Mazdutide, the First Dual GCG/GLP-1 Receptor Agonist Approval in China

Why Critical: Keynote presentation on breakthrough siRNA therapeutic technologies from leading Japanese researcher.

Impact: Insights into next-generation molecular approaches for RNA therapeutics.

Speaker:

Takeshi Wada, Ph.D.
Professor of Organic Chemistry,
Tokyo University of Science, Japan

Keep Calm and Do Chemistry: New Chemical Modifications for RNA Medicine

Why Critical: Industry-leading expertise on chemical modifications that enable RNA therapeutic success.

Impact: Practical insights from the company that pioneered RNAi therapeutics commercialization.

Speaker:

Muthiah (Mano) Manoharan, Ph.D.
Senior Vice President
Alnylam Pharmaceuticals, USA

Emerging Technologies in the Scale Up of Oligonucleotide Therapeutics

Why Critical: Big pharma perspective on manufacturing scale-up challenges and solutions.

Impact: Strategic insights into commercial-scale oligonucleotide production from industry leader.

Speaker:

Scott May, Ph.D.
VP of Chemistry
Eli Lilly & Company, USA

Thiomorpholino Oligonucleotides (TMOs) Useful for Exon Skipping, RNase H and siRNA Applications

Why Critical: Foundational insights from the pioneer of automated DNA synthesis technology.

Impact: Novel oligonucleotide chemistry with broad therapeutic applications.

Speaker:

Marvin Caruthers, Ph.D.
Distinguished Professor
University of Colorado, USA

Before You Arrive

Download the ConnectMe App Before You Arrive in Tokyo

Before arriving in Tokyo, download the ConnectMe app to plan your agenda, schedule meetings with fellow attendees, and seamlessly navigate the event at Grand Nikko Tokyo Daiba. Networking is already in full swing—all 300+ attendees are connecting, scheduling meetings, and exchanging ideas across oligonucleotide, peptide, mRNA, and genome editing disciplines. The app also provides access to recorded presentations for 2 weeks post-event, ensuring you can review any sessions you missed. Don’t miss out—join the conversation and make the most of your TIDES Asia experience!

TIDES Asia – Leaders In

24-26 February, 2026
Grand Nikko Tokyo Daiba, Tokyo

Connect with Leaders in Oligonucleotide & Peptide Therapeutics

Visit Our Booth: 11

#TIDESAsia

TIDES Asia

24-26 February, 2026
Grand Nikko Tokyo Daiba, Tokyo

TIDES Asia 2026: Bridging Research to Reality

Connect with the Top Companies Leading The Way in Oligonucleotide & Peptide Therapeutics

Start Connecting

Pre-Conference Sessions

Regulatory and Practical CMC Considerations Around Novel RNA Chemistries

Manufacturing and Characterization of Long and/or Complex Peptides

Networking Opportunities Not to Miss

Networking Cocktail Reception with Poster and Exhibit Viewing

Daily Networking Refreshment Breaks with Poster and Exhibit Viewing

Networking Luncheons

TIDES Talks in the Exhibit Hall

Not-to-Miss Sessions

Development of New Molecular Technologies for siRNA Therapeutics

The Science Behind the GLP-1 Medicines: A Historic View and Future Outlook

Clinical Development of Mazdutide, the First Dual GCG/GLP-1 Receptor Agonist Approval in China

Keep Calm and Do Chemistry: New Chemical Modifications for RNA Medicine

Emerging Technologies in the Scale Up of Oligonucleotide Therapeutics

Thiomorpholino Oligonucleotides (TMOs) Useful for Exon Skipping, RNase H and siRNA Applications

Before You Arrive

Download the ConnectMe App Before You Arrive in Tokyo

Pre-Conference Sessions

Networking Opportunities Not to Miss

Not-to-Miss Sessions

Before You Arrive

#TIDESAsia

24-26 February, 2026 Grand Nikko Tokyo Daiba, Tokyo

Connect with Leaders in Oligonucleotide & Peptide Therapeutics

Visit Our Booth: 11

#TIDESAsia

24-26 February, 2026 Grand Nikko Tokyo Daiba, Tokyo

TIDES Asia 2026: Bridging Research to Reality

Connect with the Top Companies Leading The Way in Oligonucleotide & Peptide Therapeutics

Start Connecting

Pre-Conference Sessions

Networking Opportunities Not to Miss

Not-to-Miss Sessions

Before You Arrive

#TIDESAsia

24-26 February, 2026
Grand Nikko Tokyo Daiba, Tokyo

24-26 February, 2026
Grand Nikko Tokyo Daiba, Tokyo